International Journal of Management and Applied Science (IJMAS)
current issues
Volume-4,Issue-8  ( Aug, 2018 )
Past issues
  1. Volume-4,Issue-8  ( Aug, 2018 )
  2. Volume-4,Issue-7  ( Jul, 2018 )
  3. Volume-4,Issue-6  ( Jun, 2018 )
  4. Volume-4,Issue-5  ( May, 2018 )
  5. Volume-4,Issue-4  ( Apr, 2018 )
  6. Volume-4,Issue-3  ( Mar, 2018 )
  7. Volume-4,Issue-2  ( Feb, 2018 )
  8. Volume-4,Issue-1  ( Jan, 2018 )
  9. Volume-3,Issue-12  ( Dec, 2017 )
  10. Volume-3,Issue-11  ( Nov, 2017 )

Statistics report
Nov. 2018
Submitted Papers : 80
Accepted Papers : 10
Rejected Papers : 70
Acc. Perc : 12%
Issue Published : 54
Paper Published : 3316
No. of Authors : 6857
  Journal Paper




Paper Title :
Formulation Development of a Non-Ionic Surfactant Vesicles of Gemcitabine For Pulmonary Delivery

Author :Fatima Al-Gawhari

Article Citation :Fatima Al-Gawhari , (2016 ) " Formulation Development of a Non-Ionic Surfactant Vesicles of Gemcitabine For Pulmonary Delivery " , International Journal of Management and Applied Science (IJMAS) , pp. 68-70, Volume-2,Issue-12, Special Issue-1

Abstract : Lung cancer is a major cause of death in the world. Cancer chemotherapy is limited by adverse toxicities to normal tissues. Targeted delivery of anticancer drugs to lung cancer by inhalation would help to reduce these toxicities. Lipid based delivery systems have been shown to be effective in improving the delivery of a number of drugs and the potential of using non-ionic surfactant vesicles (NIV) to improve the delivery of Gemcitabine (Gem) was studied in this research.The NIV was used to encapsulate Gem (Gem-NIV) for delivery by the pulmonary route. The NIV was prepared using concentrations of lipid (30 and 60 mM) and characterized on the basis of size, drug entrapment efficiency and zeta potential. In vivo pulmonary delivery of Gem-NIV was evaluated using two rodent models (BALB/c mice and Sprague- Dawley rats). The drug delivery study showed that inhalation of Gem treatments (both Gem and Gem-NIV) to mice resulted in high lung concentrations of Gem. The Gem lung level was higher for Gem-NIV (60 mM) treated mice at dose 14 mg/ml (0.5ml) compared with the same dose of Gem solution. In the rats, there was a greater accumulation of the Gem in the lungs of rats in comparison with other organs when administered as a NIV formulation prepared with 60 mM lipid at a dose of Gem of 6 mg/kg in comparison with NIV prepared with 30 mM. The results of these studies indicate that Gem-NIV show significant potential to improve delivery of Gem for the treatment of lung cancer using pulmonary administration compared with Gem solution alone. Keywords— Pulmonary, Gemcitabine and non-ionic surfactant vesicles.

Type : Research paper

Indexed : Google Scholar


Copyright: © Institute of Research and Journals

| PDF |
Viewed - 14
| Published on 2017-01-28
   
   
IRAJ Other Journals
IJMAS updates
IJMAS -THANK YOU ALL FOR CONTRIBUTING YOUR PAPER TO IJMAS DECEMBER ISSUE.ALL AUTHORS ARE REQUESTED TO GET THEIR HARD COPY NOW.
The Conference World

JOURNAL SUPPORTED BY